Paul Ehlinger

Founder and CEO

2022 - Current

Flamel.ai enables multi-location franchises to turn each unit into a marketing engine. Drive meaningful engagement and conversion with local, personalized content while preserving brand integrity. Check us out at: www.flamel.ai

Co-founder and Venture Partner

2020 - 2023

Seen. Heard. Funded. We are the first Indiana-based Venture Capital firm dedicated to investing in Black, Brown, Women, LGBTQ+, and disabled founders. We use capital, connections, and community to support scalable and investable tech and tech-enabled companies.

Director of Operations

2021 - 2022

Gifthealth streamlines your Rx experience with proprietary technology and a national network of pharmacy partners.

Investor/Board Member

2021 - 2021

Principal

2019 - 2021

Partnering with and building high-growth tech companies in the heart of the Midwest.

Investment Manager, Kentucky Enterprise Fund

2018 - 2019

The Kentucky Enterprise Fund (KEF) is the most active venture investor in the state of Kentucky. It is a pre-seed and seed-stage fund with an active portfolio of 60 companies (120+ in total) and >$30MM in assets under management.

Associate, KEF

2017 - 2018

R&D Engineer

2016 - 2017

I joined Wallaby Medical as the 7th employee and as a part of the core engineering team. While here, I helped develop a patented neurovascular coil system for the treatment of brain aneurysms in an international startup environment. Recently, the device received the CE Mark approval and FDA 510(k) clearance. My roles included, but weren’t limited to: managing the design of implant delivery system based on key opinion leader feedback, creating and implementing quality, test, and manufacturing protocols in accordance to ISO 13485 and good manufacturing procedures, and training and managing a team of six technicians in protocol and device development.

R&D Engineer

2015 - 2016

I began my career as an intern with Medtronic on their neurovascular R&D team. During my internship, I developed a modeling tool to reduce the need for benchtop testing of early design iterations by predicting principal strains and stresses of 3D solid models. This project led to a full time position with the R&D team where I worked with senior team members on the design of a flow-diverting neurovascular stent for the treatment of wide-neck aneurysms. My responsibilities included: development of test and manufacturing protocols, transfer of product to the main manufacturing floor, and design verification testing.

R&D Engineer Intern (Neurovascular)

2015 - 2015

Research Assistant

2012 - 2014

o Designed an ex-vivo cell culture system to investigate the effects of differentiated pressure on cardiomyocyte cells o Cultured HL-1 mouse cardiomyocyte and MCF-7 human breast cancer cells o Performed mRNA isolation, cDNA synthesis, Real-Time PCR, and radioactive ligand binding experiments on multiple mammalian cell lines to investigate adipocytokine expression o Trained new laboratory members in several key experimental methods and lab protocols

Research Assistant

2011 - 2012

o Developed and implemented a series of false positive tests for quality assurance testing of a device for the photoacoustic detection of circulating melanoma cells o Used AutoCAD software to design and then fabricate a two phase flow chamber to alleviate ambient noise in the device o Assisted a fellow undergraduate researcher in adapting the melanoma detection device to instead detect circulating E. coli bacteria o Worked cooperatively under a PhD student to build an oscillating motor for an optical surgery fiber optic despeckler